Ergoteles LLC Zai Lab LTD Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$27.77 - $64.4 $325,992 - $755,991	-11,739 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $1.2 Million - $2.29 Million	-21,811 Reduced 65.01%	11,739 $738,000
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $1.31 Million - $2.22 Million	12,450 Added 59.0%	33,550 $3.54 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $1.6 Million - $2.3 Million	12,753 Added 152.79%	21,100 $3.73 Million
Q1 2021 May 12, 2021	BUY	$126.27 - $191.71 $1.05 Million - $1.6 Million	8,347 New	8,347 $1.11 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.95B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.